Medicaid Expansion and Enhanced Coverage of Direct Oral Antivirals: Improving Care for Patients With Liver Disease
- PMID: 34418271
- DOI: 10.1002/lt.26276
Medicaid Expansion and Enhanced Coverage of Direct Oral Antivirals: Improving Care for Patients With Liver Disease
Comment on
-
Medicaid Expansion Association With End-Stage Liver Disease Mortality Depends on Leniency of Medicaid Hepatitis C Virus Coverage.Liver Transpl. 2021 Dec;27(12):1723-1732. doi: 10.1002/lt.26209. Epub 2021 Jul 20. Liver Transpl. 2021. PMID: 34118120
References
-
- Strazzabosco M, Allen JI, Teisberg EO. Value‐based care in hepatology. Hepatology 2017;65:1749‐1755.
-
- Kumar SR, Khatana SAM, Goldberg D. Impact of Medicaid expansion on liver‐related mortality. Clin Gastroenterol Hepatol 2020. https://doi.org/10.1016/j.cgh.2020.11.042 . [Epub ahead of print] - DOI
-
- Wahid NA, Lee J, Kaplan A, Fortune BE, Safford MM, Brown RS Jr, Rosenblatt R. Medicaid expansion association with end‐stage liver disease mortality depends on leniency of Medicaid hepatitis C virus coverage. Liver Transpl 2021;27:1723‐1732.
-
- Khatana SAM, Bhatla A, Nathan AS, Giri J, Shen C, Kazi DS, et al. Association of Medicaid expansion with cardiovascular mortality. JAMA Cardiol 2019;4:671‐679.
-
- Swaminathan S, Sommers BD, Thorsness R, Mehrotra R, Lee Y, Trivedi AN. Association of Medicaid expansion with 1‐year mortality among patients with end‐stage renal disease. JAMA 2018;320:2242‐2250.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical